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Three 0-acetylated gangliosides, GI, Gz,  and GS,  
were purified from bovine buttermilk by using chlo- 
roform/methanol extraction, Folch partitioning, chro- 
matography on DEAE-Sephadex A-25, and Iatrobeads 
columns. The final yields of gangliosides GI, GZ, and 
GB were 2 mg, 37 mg, and 40 mg per 1.7  kg of the 
buttermilk powder, respectively. On the basis of  im- 
munostaining on high performance thin layer chro- 
matography with specific monoclonal antibodies, mild 
alkaline treatment, gas-liquid chromatographic analy- 
sis, fast atom bombardment mass spectrometry, and 
proton nuclear magnetic resonance studies, GI and Gz 
are characterized as 0-acetylated GD3 and GB as 0- 
acetylated G T ~ ,  and the structures of these gangliosides 
are  as follows: 
GI: 
G2: 
Ga: 
NeuAc(a2+8)NeuAc(a2-3)Gal(@l+4)- 
I Glc(@l+l‘)Ceramide 
(7-,9-) 
I 
O-AQ 
NeuAc(a2+8)NeuAc(a2+3)Gal(@1+4)- 
I Glc(@l+l’)Ceramide 
(7-) or (9-) 
I 
0-AC 
NeuAc(a244)NeuAc(a2+8)NeuAc(a2~3)- 
Gal(@l-r4)Glc(j31-+l’)Ceramide 
0-AC 
The major fatty acids of these gangliosides were  C18:0, 
C22:0, C23:0, and C24:0, and the long chain base was 
C18-sphingosine. 
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The sialic acids are a diverse family of 9-carbon sugars 
found as terminal monosaccharides on  many glycoconjugates 
(3, 4). During the last few years, there  has been a growing 
interest in the occurrence, metabolism, and function of 0 -  
acetylated sialic acids of glycoproteins and gangliosides. 0- 
Acetyl esters at the 9-position of sialic acids show tissue- 
specific expression, developmental regulation, and regional 
distribution  in a  variety of tissues  and  sometimes  reappear  as 
oncofetal antigens (5-14). The  9-@acetylated disialoganglio- 
side (9-0-acetyl GD3) is selectively expressed in  the embryonic 
adrenal gland, the  mesonephron,  and  certain regions of the 
developing nervous  system,  but  not  in  other  parts of the  fetus 
(13-16). Studies  with  the monoclonal antibody  JONES have 
demonstrated  that  this  unusual ganglioside shows a dorsal- 
ventral  gradient across the developing retina, a distribution 
distinct  from  its  precursor, GD3 (6,8,17).  Similar discordance 
between GD3 and its 0-acetylated counterpart is found in 
other  areas of the developing central  and  peripheral nervous 
system (8-10, 17-19). Expression of 9-0-acetyl GD3 decreases 
shortly  after  birth  and  in  the  adult  animal  appears  confined 
to  the  adrenal medulla, the  renal glomerular  polocyte, and a 
few cells in  the  nervous  system (8-10, 17, 18). It  was found 
that only the  retina  and  the  adrenal gland showed variable 
abnormalities  in  organization, when 0-acetyl groups in  9-0- 
acetylated gangliosides were selectively  destroyed during  em- 
bryogenesis by expressing the 9-0-acetylsialic acid-specific 
esterase of influenza C (19).  These  observations uggest that 
9-0-acetylated sialic acids may play an important role in 
murine development at the 2-cell stage  and  in  certain differ- 
entiated tissues. 
We previously reported  the ganglioside composition of ham- 
ster melanomas, in which G M ~ ,  GD3, and  0-acetyl GD3 were 
expressed as the major gangliosides (20). The expression of 
0-acetyl GD3 in  melanoma cells  suggests that  its  appearance 
may  serve to  modulate  and provide  selectivity  for the  critical 
events of cell metastasis  and growth in  melanoma cells (20). 
In spite of such intriguing clues, little is known about the 
structures  and  the specific biological roles of these O-acety- 
lated gangliosides during development. The acetyl group in 
the  0-acetylated GD3 appears  to be localized at  the  9-position 
of the  terminal sialic  acid  moiety  (14, 16, 22-24). It  is  impor- 
tant, therefore, to find a good source for the large scale 
purification of these gangliosides.  Recently, we found  in bo- 
vine buttermilk  an  0-acetyl GD3 species (21) which, based  on 
its  reactivity with  specific  monoclonal antibodies, seemed to 
be  the  same  as  those xpressed in developing  nervous  system 
as well as melanoma tissues (13). A more detailed study 
revealed that  there were several different species of O-acety- 
lated gangliosides whose structures  had  not  yet been deduced. 
In  the  present  paper, we describe the  purification  and  char- 
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acterization of three 0-acetylated gangliosides from bovine 
buttermilk  and  their reactivity toward the monoclonal anti- 
bodies, D1.l (5, l l ) ,  18B8 (29),  and A2B5 (30). 
EXPERIMENTAL  PROCEDURES 
Materials-Bovine buttermilk powder was from Land O'Lakes 
(Minneapolis, MN). High performance TLC plates  (nanoplates, 10 X 
20 cm) were purchased from E. Merck, Darmstadt, Federal Republic 
of Germany. DEAE-Sephadex A-25 and Iatrobeads were from Phar- 
macia Fine Chemicals, Uppsala, Sweden, and Iatron Laboratories, 
Inc., Tokyo, Japan, respectively. The monoclonal antibody R24  was 
a generous gift  from Dr. Kenneth Lloyd (Memorial Sloan-Kettering 
Cancer Center, New York, NY), the monoclonal antibody D1.l was 
from Dr. Joel Levine (SUNY,  Stony Brook, NY), and  the monoclonal 
antibodies A2B5 and 18B8 were from Dr. George Grunwald (Jefferson 
Medical College, Philadelphia, PA). '"I-Labeled staphylococcal pro- 
tein A was supplied by  Du Pont-New England Nuclear. Horseradish 
peroxidase-conjugated goat anti-mouse IgM or IgG  was from Cappel, 
West Chester, PA. Anhydrous pyridine, hexamethyldisilazane, and 
trimethylchlorosilane were purchased from Pierce Chemical Co. All 
other chemicals were  of HPLC' or analytical grade. 
Purification of Total Gangliosides-Bovine buttermilk powder, 1.7 
kg, containing 32% protein, 8.5% minerals, 49% carbohydrates, and 
3.5% other small molecular weight compounds, was suspended in 
water and then dialyzed against distilled water to remove small 
oligosaccharides, minerals, and other small moleculer  weight material. 
After lyophilization, 1 ml  of 0.9% NaCl per  g of dry dialyzed butter- 
milk powder  was added to facilitate the ensuing extraction. The  total 
lipids were extracted from the lyophilized materials with 10 volumes 
each of ch1oroform:methanol (C:M) (2:1, 1:1, and 1:2 v/v) (25). The 
combined lipid extracts were adjusted to a  ratio of C:M:water (W) 
(2:1:0.6) and  then partitioned  three  times  (26). The ganglioside frac- 
tions from the upper phases were combined, evaporated, and dialyzed 
against deionized water for 3 days with frequent changing of water 
and  then lyophilized. The residue containing gangliosides was dis- 
solved in C:M:W (30608) (solvent A) and applied onto a DEAE- 
Sephadex A-25 chromatographic column (100 X 2.0 cm, inside di- 
ameter).  The column was washed with 10 volumes of solvent A to 
remove neutral lipids, then  the crude gangliosides were eluted step- 
wise with a solvent system of 1,000 ml each of  0.05 M, 0.2 M, and 0.8 
M sodium acetate  in solvent A. One hundred eighty 15-ml effluent 
fractions were collected. On the basis of the elution profile, fractions 
1-80  were  pooled as monosialogangliosides, 80-110 as disialoganglio- 
sides, and 110-140 as trisialogangliosides. The solvent in each fraction 
was evaporated. After removing the sodium acetate in each fraction 
by dialysis, individual gangliosides in the di- and trisialoganglioside 
fractions were separated on a Iatrobeads column (100 X 2.0 cm) with 
gradient elution using 1 liter each of  C:M:0.5% CaCl,.2H20 (7030:3 
and 35:65:5, v/v for disialogangliosides) or C:M:0.5% CaC12.2H20 
(60:405 and 35:65:10, v/v for trisialogangliosides). 
Final purification of individual gangliosides was achieved by Iatro- 
beads column (110 X 0.4 cm) chromatography as follows. 0-Acetylated 
Go:$ was purified by gradient elution using C:M:W  (70:30:3 and 
35:65:5, v/v) and 0-acetylated GT3 by gradient elution using C:M:W 
(65:35:5 and 30:7010, v/v). The purity of each 0-acetylated ganglio- 
side species was examined by high performance thin layer chroma- 
tography (HPTLC) with two different solvent systems: (a) n-propyl 
alcoho1:water (80:20, v/v) and (b) C:M:0.5% aqueous CaC12.2H20 
(55:45:10, v/v). The gangliosides were visualized on the plate by 
spraying with the resorcinol-HC1 reagent (27) followed  by heating at 
95 "C for 30 min. 
Mild  Alkali Treatment of 0-Acetylated Gangliosides-One hundred 
pg of a ganglioside sample was treated with 0.2 N methanolic NaOH 
at  37 "C for 2 h. The reaction mixture was then neutralized with 0.2 
N HC1, and  the salts in the mixture were  removed  by a Sephadex LH- 
20 column (47 X 0.5 cm, inside diameter; 23-ml bed volume) by 
elution with C:M:W (30:60:8). 
' The abbreviations used are: HPLC, high performance liquid chro- 
matography; HPTLC, high performances thin layer chromatography; 
'H NMR, proton-nuclear magnetic resonance; HOHAHA, homonu- 
clear Hartman-Hahn spectroscopy; FAB, fast-atom bombardment 
BSA/PBS, bovine serum albumin in phosphate-buffered saline; mAb, 
monoclonal antibody. The ganglioside nomenclature follows the sys- 
tem of Svennerholm (1) and a recent IUPAC-IUB recommendation 
(2). 
HPTLC Overlay of 0-Acetylated Gangliosides-HPTLC overlay 
was carried out according to Kasai et al. (28). Briefly, the gangliosides 
were chromatographed on an HPTLC plate with the developing 
solvent system of C:M:0.5% aqueous CaC12.2H20 (55:45:10, v/v). 
After chromatography, the plate was dried in vacuo for 2 h  and dipped 
in  a solution of 0.4% poly(isobuty1 methacrylate) in n-hexane for 1 
min and dried in vacuo. The plate was incubated with 1% BSA in 
PBS (BSA/PBS) (pH 7.4) at room temperature for 90 min and  then 
overlaid with monoclonal antibodies D1.l, A2B5,  or 18B8 at a dilution 
of  1:50-100 in BSA/PBS. After incubation at room temperature for 
90 min, the plate was washed with PBS five times. The plate overlaid 
with D1.1  was  covered with horseradish peroxidase-conjugated goat 
anti-mouse IgM or IgG at a dilution of 1: lOO in BSA/PBS for 90  min 
and washed as described above. After washing, the plate was incu- 
bated for a few minutes with 0.5 mg/ml 4-chloro-1-naphthol and 
0.01% HZ02 as substrate. 
The plates overlaid with A2B5 and 18B8 were  covered  by goat anti- 
mouse  Ig at a dilution of 1: lOO in BSA/PBS for 60 min. After washing 
with PBS, the plates were  covered with 2 ml  of '251-labeled staphylo- 
coccal protein A (lo6 cpm/ml), incubated for 60 min, and washed 
with 0.1% Triton X-100 in 0.9% NaC1,  followed  by exposure to an x- 
ray film. 
Compositional Analysis-To determine the sugar and fatty acid 
compositions, gas-liquid chromatographic (GLC) analysis was carried 
out according to  the procedure of  Ariga et al. (31) with slight modifi- 
cations. A ganglioside sample, containing about 50 pg of sialic acid, 
was subjected to methanolysis for 18 h at 75 "C with 1 ml of 1% 
methanolic hydrogen chloride. Following methanolysis, the resulting 
fatty acid methyl esters were extracted with n-hexane, and the extract 
was evaporated and dissolved in 50 pl  of n-hexane. An aliquot of this 
solution was injected onto  a column of HP5 (cross-linked 5% PhMe 
Silicone, 25 m X 0.2 mm X 0.5 pm film thickness) maintained at 
270 "C for analysis of fatty acids. The lower methanolic layer was 
evaporated under a stream of nitrogen and dried in uacuo. The 
dried residue  was treated with  100  pl of hexamethyldisilazane: 
trimethylchlorosi1ane:pyridine (1.3:0.8:l,v/v) at 60 "C for 5 min, and 
the resulting trimethylsilylated derivatives of the saccharides were 
220 to 270  "C. 
analyzed by GLC on the  HP5 column programmed at 3 "C/min from 
Fast-atom Bombardment (FAB) Mass Spectrometry-Negative ion 
FAB mass spectra were obtained by a  TSQ 70 triple-stage quadrupole 
mass spectrometer (Finnegan MAT Inc., San Jose, CA) equipped 
with a FAB  ion source. Xenon gas  was used at 8 kV as  an ionization 
beam. A ganglioside sample, 30 pg,  was dissolved in 10 p1 of  C:M (1:1, 
v/v). Triethano1amine:tetramethylurea (Ll, v/v, 2 pl) was added, and 
the solvent mixture (about 1 p l )  was applied to a stainless steel 
sample holder. The sample was analyzed as described previously (31). 
Proton Nuclear Magnetic Resonance  Spectroscopy-Samples  were 
prepared for 'H NMR analysis as described previously (32, 33). 
Briefly, each sample, 2 mg, was dissolved in 0.5  ml  of  D,O and 
lyophilized to remove exchangeable protons. The residue was dis- 
solved in 0.5  ml  of dimethyl sulfoxide-d6/D20 (98:2, v/v). NMR 
spectra were obtained on spectrometers operating at 'H frequencies 
of  300 MHz or 500 MHz. 
Resonance assignments were  made largely on the basis of a 300- 
MHz two-dimensional Homonuclear Hartman-Hahn spectroscopy 
(HOHAHA) data  set which  was acquired with a mixing time of 80 
ms and a spin lock  field strength of 8 kHz. This  data set consisted of 
384 tl increments. Each tl increment consisted of 1024  complex points 
over a 2401-Hz sweep width averaged for 256 transients with a 1.1 
second repetition rate. Quadrature detection was achieved in the f l  
dimension using hypercomplex phase cycling with real and imaginary 
tl points stored separately. Data were processed for phase-sensitive 
display using FELIX 2.0 (Hare Research, Bothell, WA) with cosine 
bell  weighing functions and zero filling in both dimensions to yield a 
2K x 2K data matrix. 
RESULTS 
After Folch partitioning, 4.12 g of lipid extract were re- 
covered from 0.67 kg of lyophilized materials after dialysis. 
About 360 mg  of mono-, 680 mg  of di-, and 196 mg  of 
trisialoganglioside fractions were  recovered from the DEAE- 
Sephadex A-25 column (see "Experimental Procedures"). Fig. 
1 shows the elution profile for bovine buttermilk gangliosides. 
At least  three alkali-labile gangliosides,  which  were designated 
as GI, G1, and GB, could  be detected on the basis of mild alkali 
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CTlb 
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FIG. 1. HPTLC ganglioside profile of bovine buttermilk. 
The profile  was obtained by eluting the gangliosides from a DEAE- 
Sephadex A-25 column. Two pl from each of individual fractions were 
spotted on the plate. The developing solution was solvent system b 
(see “Experimental Procedures”). The spots were located with resor- 
cinol-HCI reagent. Lane S, standard gangliosides; lane M, a mixture 
of gangliosides extracted from bovine buttermilk. Three acetylated 
gangliosides, designated as GI, GB, and G3, were recognized on the 
profile. 
1 
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GDla 
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FIG. 2. HPTLC purification profiles of 0-acetylated G D ~  
gangliosides from bovine buttermilk. 0-Acetylated G D ~  was pu- 
rified from the disialoganglioside fraction by Iatrobeads column chro- 
matography. The developing solution was solvent system b (see 
“Experimental Procedures”). The spots were located with resorcinol- 
HC1 reagent. Lane SI, standard gangliosides; lane S2, standard gan- 
glioside G D ~ .  0-Acetylated ganglioside GDs was separated from G D ~  
and could  be  recognized on the plate. 
G3 
-. 
50 100 150 II 
FIG. 3. HPTLC purification profiles of 0-acetylated G T ~  
gangliosides from bovine buttermilk. 0-Acetylated G T ~  was sep- 
arated from trisialoganglioside GW, which  is around fraction 100, by 
Iatrobeads column chromatography. Other conditions were the same 
as described in Fig. 2. 
treatment as described later. As previously reported (34), 
bovine buttermilk was found to  contain 0.92 umol of liDid- 
migrated between GMp and  GM~,   and  G3 between Goa and GD~,. 
Table I shows the results of compositional analysis of the 
carbohydrates and fatty acids of GD3, GI, G2, GTR, and Gs. 
Gangliosides GI  and G2 contain glucose, galactose, and sialic 
acid in a molar  ratio of 1:1:2, and G3, 1:1:3, respectively. The 
fatty acid  composition of these gangliosides is shown in  Table 
I. The major fatty acids were stearic, behenic,  tricosanoic, and 
tetracosanoic acids. 
The purified gangliosides, GI  to GI, were subjected to al- 
kaline  treatment (see “Experimental Procedures”).  After mild 
alkaline treatment, the degradation products from ganglio- 
sides GI  and  Gp co-migrated on  TLC with authentic G D ~ ,  while 
G3 co-migrated with GT3, as shown in Fig. 4. These data 
suggest that  these alkali-labile gangliosides may contain 0- 
acetylated sialic  acid residues. 
Fig. 5 shows the negative  ion-FAB  mass spectra  and frag- 
mentation  diagrams of gangliosides GD3, GI,  and GB, which 
were isolated from bovine buttermilk.  In  the mass spectra of 
G D ~  (Fig. 5A) ,  GI (Fig. 5B) ,  and G3 (Fig. 5C), five ion  groups 
are clearly  discernible  which arise from  ceramide and ceram- 
ide-bearing fragment ions. In  the  mass  spectrum of GD~,   t he  
prominent molecular ions [M + Na - 2H]- are clearly  seen 
TABLE I 
Sugar and fatty acid compositions of gangliosides isolated 
from bovine buttermilk 
Gangliosides 
G D ~  GI G2 G3 GT? 
Sugars 
Glc 1 1 1 1 1 
Gal 1.09 0.98 0.85 1.02 1.01 
Sialic acid 2.16 1.79 1.85 2.98 2.87 
140 2 Trace Trace Trace 2.5 
161 0 0 Trace Trace 0 
16:O 7.7 1.9 2.2 10.8 7.4 
181 Trace 3.3 11.8 6.6 10.7 
180 3.7 7.4 22.4 38.3 15.6 
2 0  1 Trace Trace Trace Trace Trace 
200 1.6 1.2 1.0 2.6 1.4 
21:o 1.7 Trace 1.2 Trace 1.2 
220 27.3 25.0 15.7 18.0 19.1 
230 31.7 30.9 19.6 13.0 21.4 
241 2.9 2.5 2.1 Trace 1.5 
24:O 19.3 25.2 18.6 6.7 19.1 
25:O 1.5 1.4 1 Trace Trace 
Fatty acid ( % ) 
F 
Gu3 
GD3 
GT3 
. . . . . . . . - . . . . . . .  
bound sialic acidlg  dry weight. The  concentrations of acety- 
lated gangliosides GI, GB, and G3 are 0.4% (2  mg), 5% (37 mg), 
and 6% (40 mg) of the  total lipid-bound sialic acid, respec- FIG. 4. HPTLC of purified 0-acetylated gangliosides 
treated with methanolic NaOH. Lane I ,  standard gangliosides; 
S I1 B 1   N 2   B 2   N 3   B 3  
tively’ Figs’ and show the ganglioside profiles from lanes NI, N2, and N3 correspond to untreated GB, GI, and Gs, 
Iatrobeads column  chromatographies. Three gangliosides, GI respectively; lanes BI,  B2, and 83 to treated GP, GI, and G3, respec- 
t o  Gs, were isolated and purified to homogeneity. Ganglioside tively. Other conditions were the Same as described in Fig. 3. The 
GI  migrated slightly further than ganglioside G2, while G2 bands were  visualized  by spraying with the resorcinol-HCI reagent. 
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FIG. 5. The negative ion-FAB mass spectra and fragmen- 
tation diagrams of G D ~  ( A ) ,  G I  ( B ) ,  and G p  (C). 
in which the major ions at  m/z 1548,  1562, and 1576 provide 
information on  the molecular weights of GD3 molecular species 
with C18-sphingosine and C22:0,  C23:0, and C24:O fatty acids, 
respectively. These ions are also present  in the spectra of Gl 
and G,. However, the quasimolecular ions for G1 and G, are 
shifted by  84 and 42 mass units from those observed for GD3, 
respectively, suggesting the presence of two and one 0-acetyl 
groups in G1 and G,, respectively. For example, the ions at  
m/z  1632,1646, and 1660 in G1 correspond to di-0-acetyl G D ~  
ganglioside with Cl8-sphingosine and C22:0,  C23:0, and  C240 
fatty acids, respectively. In  the case of G,, these  ions are of 
relatively low intensity, but  the ions 1590,  1604, and 1618 are 
prominent, which provides information on the molecular 
weight of the monoacetyl GD3 molecular species. 
In all spectra in Fig. 5, A, B, and C, the fragment ions 
corresponding to  the formal elimination of 1 or 2 sialic acid 
units  and 2 hexose units from the molecular ions are detected 
at  m/z 1235,1249, and 1263 (fragment group d), m/z 944,958, 
and 972 (fragment group c), m/z 782,796, and 810 (fragment 
group b), and m/z 620, 634, and 648 (fragment group a), 
respectively. Owing to  the detection of three ions, m/z 1235, 
1249, and 1263 in the spectra of both G1 and GP (Figs. 5, B 
and C ) ,  the  0-acetyl groups must be attached  to  the terminal 
sialic acid in the molecule. 
Fig. 6 shows the FAB mass spectra of GT3 and G3. In both 
spectra, six major ion groups are present, which arise from 
ceramide and ceramide-bearing fragment ions. In both spec- 
tra, ion regions are complex, probably due to  the presence of 
quasimolecular ions containing [M - HI- and [M + Na - 
2H]-. For example, prominent molecular ions [M - HI- are 
detected at  m/z 1839,1853, and 1867 which correspond to  the 
molecular species with C18-sphingosine and C22:0,  C23:0, and 
C24:O fatty acid, respectively. The less prominent  ions a t  m/ 
z 1876 and 1890 correspond to [M + Na - 2H]- ions with 
CWsphingosine and C23:O and C24:O fatty acids, respec- 
tively. In  the spectra of G3, all these  ions are shifted by 42 
mass units; therefore, G3 is supposed to be mono-0-acetyl 
B 
[II-EI- 
so0 1000 IS00 
FIG. 6. The negative ion-FAB mass spectra and fragmen- 
tation diagrams of GT3 ( A )  and G3 ( B ) .  
UI 
01. 
. ODlb 
. mlb 
1 2 3 4 5 6  1 2 3 4 5 6  
FIG. 7. Detection of 0-acetylated ganglioside G D ~  on 
HPTLC plate by immunoreactivity with monoclonal antibody 
D1.l. A, gangliosides reacting  with monoclonal antibody DL1 and 
horseradish  peroxidase  conjugate  (see "Experimental Procedures"; B, 
gangliosides visualized with the resorcinol-HC1 reagent. Lanes 1-5 
correspond to GI, G2, GD3, Gn, and Gn, respectively; lane 6, standard 
gangliosides. Each  lane  contains 2-5 pg of lipid-bound  sialic acid. 
GTR. In both  spectra, three major fragment ions corresponding 
to  the successive elimination of NeuAc ( e ) ,  NeuAc ( 4 ,  NeuAc 
( c ) ,  hexose (Gal) ( b ) ,  and hexose (Glc) (a )  are detected at  ml 
z 1548,1562, and 1576 for G D ~ ,  m/z 1235,1249, and 1263 for 
GH3, m/z 944,958, and 972 for LacCer, m/z 782,796, and 810 
for GlcCer, and m/z 620,  634, and 648 for ceramide, respec- 
tively. Since the ions m/z 1548,1562, and 1576 corresponding 
to GD3 are  not shifted, the 0-acetyl group of G T ~  must also be 
attached to  the terminal sialic acid residue in the molecules. 
In order to confirm the  structures of the alkali-labile gan- 
gliosides, gangliosides G1, G,, and GB were analyzed by the 
HPTLC-overlay method using specific monoclonal antibodies 
against  0-acetylated gangliosides. As shown in Figs. 7 and 8, 
GI and Gz reacted with the monoclonal antibody D1.l which 
is specific for 9-0-acetyl GD3 (14), and Gs reacted with the 
monoclonal antibody A2B5 (29) but did not react with 18B8 
which is specific for GT3 (30). The product of GR after mild 
alkaline treatment, however, reacted with 18B8. These data 
suggest that gangliosides G1 and Gz contain  0-acetylated G D ~  
and Ga is 0-acetylated G T ~ .  
Although the mass spectrometric and immunochemical 
data provide clear evidence for the presence of both mono- 
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and di-0-acetylated gangliosides, these data  cannot provide 
us with any information concerning the sites of 0-acetyl 
substitution  on the terminal a-NeuAc residue. Such data  can 
be provided by nuclear magnetic resonance assignment data 
for these compounds as the chemical shifts of resonances 
corresponding to  the sites of 0-acetylation are likely to differ 
significantly from the same protons in the unsubstituted 
gangliosides. These resonance assignments, which were made 
on  the basis of a two-dimensional HOHAHA data set, are 
summarized in Table 11. In addition, the regions of the HO- 
HAHA data set which contain the downfield shifted reso- 
nances corresponding to  the sites of 0-acetylation are pro- 
vided in Fig.  9. 
From the  data in Table I1 and in Fig. 9, it  is clear that  the 
sample used for NMR analysis consisted of a mixture of 
mono- and disubstituted GD~.  In  Fig.  9A,  we present the region 
of the HOHAHA data  set containing the downfield shifted 
resonances from the monosubstituted species (Gz). From these 
data,  it is clear that  there  are two distinct monosubstituted 
species. In one species, the most striking feature was the 
Ocl 
GDl. 
s 1 2 3 4  s 1 2  3 4 s 1 2 3 4  
FIG. 8. Detection of 0-acetylated  ganglioside G T ~  on 
HPTLC  plate  by  immunoreactivity  with  the  monoclonal an- 
tibodies A2B5 and 18B8 (see  “Experimental  Procedures”). A, 
the bands were visualized by spraying with the resorcinol  reagent; B, 
gangliosides reacting with the monoclonal antibody A2B5; C, ganglio- 
sides reacting with the monoclonal antibody 18B8. Lanes 1, 2,3,  and 
4 correspond to 0-Ac G T ~  (G3), base-treated 0-Ac G T ~  (Gn),  GTs, and 
a mixture of trisialogangliosides from bovine buttermilk, respectively; 
lane S, standard gangliosides. Each  lane contains 2 pg  of lipid-bound 
sialic acid. 
resonance a t  4.82 ppm. This resonance was assigned to  the 
H9b  proton which is shifted downfield  by  more than 1 ppm 
from the H9b resonance position in unsubstituted GD3. In 
addition, significant downfield shifts were noted for the H9a 
and  H8 resonances. Based on these chemical shift differences, 
we conclude that this monosubstituted ganglioside corre- 
sponds  to  9-0-Ac GD3. In  the  other monosubstituted ganglio- 
side, the most significant downfield shift is observed for the 
H7 resonance which is shifted to 4.15 ppm from its position 
a t  3.21 ppm in unsubstituted GD3. In addition, we noted a 
significant downfield shift for the  H8 resonance in this gan- 
glioside.  On the basis of these  shift differences, we conclude 
that this ganglioside corresponds to 7-0-Ac GD3. Although 
shift perturbations were also noted for the H9a and H9b 
resonances in  7-0-Ac GD~,  these  perturbations were somewhat 
smaller in magnitude than  the perturbations noted for down- 
field shifts noted for the H9a and H9b resonances in 9-0-Ac 
GD~.  These data suggest that GB ganglioside is a mixture of 7- 
@acetyl and 9-@acetyl Goa. 
In Fig.  9B, we present the region of the two-dimensional 
HOHAHA data set containing the downfield shifted reso- 
nances for disubstituted species (G1). Comparison of the  data 
in Fig. 9B with the data shown in Fig. 9A shows that the 
spectrum of the di-0-acetyl species is similar to  the spectrum 
which would  be obtained by summing the spectra of the two 
mono-substituted GD3 species in Fig, 9A. These data are 
largely confirmed in the assignment data presented  in  Table 
11. In  this ganglioside (G1), we see large downfield shifts for 
the H7, H8, H9a, and H9b resonances. Therefore, we conclude 
that  this diacetylated species corresponds to (7, 9)-di-O-Ac 
GD~. Closer examination of the  data in  Table I1 indicates that 
the resonance positions for the H9a and H9b resonances are 
not identical with the positions observed in  9-0-Ac GD3. These 
differences are likely indicative of some interaction between 
the two 0-acetyl groups in the disubstituted species. Com- 
bined with the  data from mobilities on HPTLC, mass spec- 
trometric, and TLC immunostaining analysis, the results 
suggest a structure of  G1 most consistent with 7,g-di-O-acetyl 
GD3 (acetylz-0-7, 9NeuAca2~NeuAca2+3Gal~l4Glc~l+  
TABLE I1
Chemical shifts  for gangliosides Go3 and 0-acetyl Grin 
Residue 
H-1 H-2 H-3 H-4 H-5 H-6 H-7 H-8 H-9 
GD3“  
I. 
11. 
A. 
C. 
0-AC Gon 
I. 
11. 
A. 
4.16 3.05 3.31 
4.27 3.28 3.63 
1.69(a) 
2.34(e) 
1.39(a) 
2.77(e) 
4.12 3.02 3.30 
4.30 3.30 3.83 
1.47(a) 
2.35(e) 
3.28 3.28 3.60(a) 
3.73(b) 
3.87 3.35 3.45(a) 
3.47(b) 
3.83 3.57 3.14 3.43 3.43 3.55(a) 
3.81(b) 
3.46 3.57  3.33 3.21 3.48 3.32(a) 
3.58(b) 
3.24 3.43  3.63(a) 
3.71(b) 
3.77 3.49 3.15 3.42 3.42 3.50(a) 
3.80(b) 
C.(7-0-) 1.40(a) 3.49 3.39 3.28 4.15 3.92 3.15(a) 
2.70(e) 
-
3.75(b) 
(9-0-1 1.4oiaj 3.49 3.39 3.28 3.27 3.82 3.90(a) 
2.70(e) 
2.70(e) 
- 
4.82(b) 
5.02(b) 
(7,9-0-) 1.40(a) 3.49 3.39 3.28 - 4.26 4.06 - 3.69(a) - 
- 
Cited  from Refs. 32 and 33. 
 at R
sch Cntr Julich Res library on January 23, 2008 
w
w
w
.jbc.org
D
ow
nloaded from
 
0-Acetylated  Gang iosides in Bovine Buttermilk 12637 
? 
m 
$ 5 ?  
P 
? 
0 
4.8 4 . 4  4 . 0  3.6 3.2 
( P P m )  
FIG. 9. A ,  plot of the region from the two-dimensional HOHAHA 
data set containing downfield shifted resonances in monoacetylated 
GI):* species. Resonances corresponding to 7-0-Ac G D ~  are labeled C' 
while resonances corresponding to  9-0-Ac GD3 are labeled C". B, plot 
of the region  from the two-dimensional HOHAHA data set  containing 
downfield shifted resonances in the diacetylated G D ~  species. Reso- 
nances corresponding to downfield shifted  protons  are labeled C. 
II I 
H OH 
C e r  
FIG. 10. The  structure of di-0-acetylated G D ~  purified  from 
bovine  buttermilk. 
1'-Cer, 7,9-di-0-Ac GD3). The proposed molecular structure 
for  the  di-0-acetyl GD3 is presented  in Fig. 10. 
DISCUSSION 
Gangliosides in bovine buttermilk (Table 111) are mainly 
present in the milk fat globule membrane which  derives from 
the apical plasma membrane of the secretory cells in the 
lactating bovine mammary gland (35, 36). The ganglioside 
content  and composition of the  buttermilk have  been studied 
by several groups (21, 33, 37, 38).  In  the  present  study, we 
dialyzed the buttermilk against water. This procedure not 
only saves  organic solvents by  removing effectively all  small 
dialyzable substances, which consist of 61% by weight of the 
buttermilk powder, but also facilitates  the recovery and  pu- 
rification of the gangliosides. Our  data for ganglioside content 
and composition are  different from that  reported by Takam- 
izawa et al. (34)  who  failed to  detect  any  0-acetylated ganglio- 
side species. The discrepancy could be due to the relative 
instability of the  0-acetylated species  which would have  been 
destroyed  during  the  base  treatment  step used in  their  gan- 
glioside isolation procedure. Takamizawa et al. (34) also re- 
ported  that  about 90% of the gangliosides in bovine buttermilk 
consisted of hemato-series gangliosides, such  as GMa, GDZ, and 
GT3. We found that about 10% of these gangliosides were 
acetylated  on  the  terminal sialic  acid  residue.  More  recently, 
we reported  the presence of 0-acetyl GD3 in  bovine buttermilk 
(21)  and suggested that  this  is a convenient  and easily  avail- 
able  source for this ganglioside. In  the  present  study, we have 
extended the previous study and found at  least three 0- 
acetylated gangliosides in bovine buttermilk. 
Since Cheresh et al. (14) reported that the monoclonal 
antibody  D1.l recognized 9-0-acetyl G D ~  on  human  melanoma 
cells, which was characterized by alkaline treatment, im- 
munostaining, and periodate oxidation, several groups re- 
ported that the alkali-labile ganglioside migrating between 
GMl and GM2 and  reacting  with mAb D1.l is 9-0-acetyl G D ~  
(15, 21). Constantine-Paton et al. (6)  found  that  the  antigen 
recognized by JONES  antibody is 9-0-acetylated ganglioside 
GD3. In  addition  to  the mAbs D1.l  and  JONES,  the receptor- 
destroying enzyme of influenza C  virus, sialate O-acetylester- 
ase  (39),  and  cancer  antennarius  lectin  (23)  can also  confirm 
the presence of 9-0-acetylation on the sialic acid residues. 
More recently,  Drazba et al. (40) reported  that  an  antigen of 
the developing. chick retina recognized by the monoclonal 
antibody A2B5 was a 9-0-acetylated ganglioside. However, 
none of them excluded the possibility of two  acetyl  groups (7 
and  9) co-existing in  the  terminal sialic  acid  residue of this 
molecule, nor  did  they rule out  the possibility  for the presence 
of 7-0-acetyl GD3 which might  react with these monoclonal 
antibodies.  In  the  present  study,  the purified 7,g-O-diacetyl 
G D ~  (G1) and a mixture of 7-0-acetyl  and  9-0-acetyl GD3 (G2) 
from  bovine buttermilk powder having a similar  mobility on 
the  HPTLC,  reacted  with mAbs D1.l  and  JONES. All these 
species were converted to GD3 after mild alkali treatment. 
However, FAB-mass  and  NMR  spectra suggested that G1 was 
7,9-0-diacetyl GD3 and  GZ a mixture of 7-0-acetyl  and  9-0- 
acetyl G D ~ .  It  should  be  pointed  out  that  our resonance as- 
signments are somewhat different from those reported by 
other workers  (16, 22). Many of these previous assignments 
have relied extensively on well resolved resonances in 'H 
NMR  spectra.  On  the  other  hand, we have relied extensively 
on  through-bond  correlated  experiments for our  assignment 
data.  Thus, we are  not  limited  to relying solely on  the rela- 
tively few well resolved resonances  in  the 'H NMR  spectra of 
these  0-acetylated G D ~  species. Given the extensive resonance 
overlap which characterizes the 'H NMR spectra of carbo- 
hydrates  and  the  additional complication that  the 'H NMR 
spectra of 0-acetylated GD3 actually  represents a  superposi- 
tion of the  'H  NMR  spectra of the two mono-0-acetylated 
species and the di-0-acetylated species, these two-dimen- 
sional  experiments offer  significant advantages  in  obtaining 
unambiguous  resonance  assignments for these compounds. 
Although the difference of functional significance  between 
7-0-acetyl GD3 in  buttermilk  and  9-0-acetyl GD3 in melanoma 
is  not  yet  understood,  it  is possible that  different  positions of 
0-acetylation  in ganglioside might  play  a  significant  role in 
cell differentiation  and cell growth. Dubois et al. (29)  reported 
the presence of alkali-labile ganglioside Grp3 in 10-day-old 
chicken embryonic retina and recently confirmed that the 
ganglioside is 9-0-acetylated GT3 by using immunostaining 
with A2B5 and  18B8 monoclonal antibodies.  Hirabayashi et 
al. (41)  found  9-0-acetyl G T ~  in  fetal  rat  cerebral cortex by 
using  the  receptor-destroying enzyme of influenza  C  virus and 
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TABLE 111 
Gangliosides of bovine buttermilk 
Ganglioside  Structure  Concentration 
GMM~ 
nrnollg dry wt 
NeuAca2+3Galfll+4Glcfll+Cer 19.98 
Galfll+4GlcNAcfll 
I 
BG“ 6(3)Galfll+4Glcfll+lCer  41.40 
I 
NeuAca2+6Galfll+4G1cNAcfll 
Acz-O-7,9NeuAca2+8NeuAca2+3Ga1@1+4Glcfll+lCer 0.72 
AC -O-7/9NeuAca2~8NeuAca2+3Galfll~4Glcfll+lCer 13.88 
NeuAca2-*8NeuAca2+3Galfll+4Glcfll+lCer 204.93 
A c - 0  11.87 
I 
NeuAca2+8NeuAca2-*8NeuAca2+3Gal@l”~4Glcfll+lCer 
GTM~ NeuAca2~8NeuAca2+8NeuAca2+3Gal@l+4Glc@l+lCer 12.73 
’ Cited from  Ref. 34. 
base treatment. The precise chemical structures of these 
gangliosides, however, have not been carefully examined. In 
this investigation, we found and characterized the  0-acetyl 
G T ~  in bovine buttermilk by using chemical and immunologi- 
cal methods and provided conclusive evidence that the 0- 
acetyl group is present at the terminal sialic acid residue. 
Because of its reactivity with mAb  A2B5, but  not with mAb 
18B8, it suggests that  the position of the acetyl group is most 
likely to be at the 9- and/or 7-0-position on the terminal 
sialic acid residue. The  data also suggest that  the free terminal 
sialic acid  residue is  important for the interaction of GT3 with 
mAb  18B8. These results are  consistent with those reported 
from chicken embryonic retina (29). Further  studies  are 
needed to clarify the position of the 0-acetyl group in 0- 
acetylated GT3. Nonetheless, this is also the  first report for 
the presence of 0-acetyl GT3 in bovine buttermilk. Since 
buttermilk is commercially available, it represents  a conven- 
ient source for the isolation of this ganglioside. 
0-Acetylated gangliosides, including 7-0-acetyl GD3, 9-0- 
acetyl GD3, 7,9-di-O-acetyl G D ~ ,  and  0-acetylated G T ~  increase 
the possible number of these molecular species leading to a 
larger diversity in the pattern of cell surface gangliosides. 
Although these species have been described originally in de- 
veloping rat  and chicken nervous systems, and  human mela- 
nomas several years ago, functional  studies have been scanty 
so far. The availability of large quantities of 0-acetylated 
gangliosides from  bovine buttermilk would facilitate greatly 
the study of the function of 0-acetylated gangliosides in 
cellular differentiation and development. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
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